Related Experiment Video
Updated: May 15, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
[Cytomegalovirus infection in infants with perinatal damage of the central nervous system]
Insights
Cytomegalovirus (CMV) DNA was detected in nearly 19% of infants with perinatal central nervous system damage. This viral activity may worsen neurological symptoms, necessitating early CMV testing and antiviral treatment.
Area of Science:
- Virology
- Pediatric Neurology
- Infectious Diseases
Background:
- Infants with perinatal central nervous system (CNS) damage require thorough etiological investigation.
- Cytomegalovirus (CMV) is a potential opportunistic pathogen in immunocompromised individuals and neonates.
Observation:
- A virological study was conducted on 90 infants (7 days to 12 months) with perinatal CNS damage.
- CMV DNA persistence was identified in blood, urine, and oropharyngeal swabs of 18.9% of the children.
- CMV DNA was exclusively found in oropharyngeal swabs and urine in 14.4% of cases.
Findings:
- The presence of CMV DNA in blood was associated with neurological symptom severity.
- CMV infection may contribute to increased blood-brain barrier permeability.
- Absence of positive treatment response in some cases could be linked to active CMV infection.
Implications:
- A comprehensive immunological and molecular survey is recommended for infants with suspected CMV infection.
- Early detection of CMV DNA warrants prompt initiation of specific antiviral therapy.
- Understanding CMV's role in CNS damage can guide pediatric neurological care and treatment strategies.
Abstract:
Ninety children, aged from 7 days to 12 months, with perinatal damage of the central nervous system (CNS) were virologically tested. The persistence of cytomegalovirus (CMV) DNA in the blood, urine and oropharyngeal swabs was identified in 18.9% of children. In 14.4% of children, CMV DNA was found only in oropharyngeal swabs and urine samples. In some cases, the severity of neurologic symptoms and absence of positive changes in the restoration treatment could be caused by the activity of CMV infection, blood CMV DNA and the increase in blood-brain barrier permeability. The authors recommend performance of a comprehensive immunological and molecular-biological survey in patients with suspected CMV infection. In case of positive reactions, a specific antiviral treatment should be started. Tree clinical cases are reported.
More Related Videos
Related Concept Videos
Cytomegalovirus Disease
Encephalitis ll: Pathophysiology
Viral Meningitis
Encephalitis l: Introduction
Arboviral Encephalitis
Bacterial Meningitis II: Pathophysiology

